APOA mimetic peptide 4F (L-4F) exerts an anti-inflammatory effect by reducing levels of tumor necrosis factor (TNF-α) and interleukin-6, which have been shown to Inhibit cancer development both in vitro and in vivo [31]. This evidence concerns the gene APOA1 and cancer.